Skip to search.
 FTSE 100 Up 0.49%

Abaxis, Inc. (ABAX)

-NasdaqGS
52.71 Up 1.64(3.20%) 19:51 - Nasdaq Real Time Price
Prev Close:51.07
Open:51.31
Bid:52.53 x 300
Ask:52.60 x 400
1y Target Est:48.79
Beta:1.30979
Earnings Date:26 Jan - 30 Jan (Est.)
Day's Range:51.28 - 52.98
52wk Range:37.71 - 58.15
Volume:175,941
Avg Vol (3m):147,295
Market Cap:1.19b
P/E (ttm):34.18
EPS (ttm):1.54
Div & Yield:0.56 (1.11%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABAX at this time.

Comparison

Symbol% ChgMkt Cap
ABAXUp 3.20%1.19b
HSKAUp 0.82%467.54m
IDXXUp 1.03%10.34b
ALRUp 0.56%3.46b

Key Statistics

Forward P/E (1 yr):35.30
P/S (ttm):5.09
Ex-Dividend Date:29-Nov-16

Analysts

Annual EPS Est (Mar-17) :1.34
Quarterly EPS Est (Dec-16) :0.33
Mean Recommendation*:3.1
PEG Ratio (5 yr expected):2.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback